These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 14733615
1. Elucidation of eukaryotic elongation factor-2 contact sites within the catalytic domain of Pseudomonas aeruginosa exotoxin A. Yates SP, Merrill AR. Biochem J; 2004 May 01; 379(Pt 3):563-72. PubMed ID: 14733615 [Abstract] [Full Text] [Related]
2. Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry. Jørgensen R, Merrill AR, Yates SP, Marquez VE, Schwan AL, Boesen T, Andersen GR. Nature; 2005 Aug 18; 436(7053):979-84. PubMed ID: 16107839 [Abstract] [Full Text] [Related]
3. The nature and character of the transition state for the ADP-ribosyltransferase reaction. Jørgensen R, Wang Y, Visschedyk D, Merrill AR. EMBO Rep; 2008 Aug 18; 9(8):802-9. PubMed ID: 18583986 [Abstract] [Full Text] [Related]
4. Insight into the catalytic mechanism of Pseudomonas aeruginosa exotoxin A. Studies of toxin interaction with eukaryotic elongation factor-2. Armstrong S, Yates SP, Merrill AR. J Biol Chem; 2002 Nov 29; 277(48):46669-75. PubMed ID: 12270928 [Abstract] [Full Text] [Related]
5. Toward the elucidation of the catalytic mechanism of the mono-ADP-ribosyltransferase activity of Pseudomonas aeruginosa exotoxin A. Armstrong S, Merrill AR. Biochemistry; 2004 Jan 13; 43(1):183-94. PubMed ID: 14705944 [Abstract] [Full Text] [Related]
6. Structure-function analysis of water-soluble inhibitors of the catalytic domain of exotoxin A from Pseudomonas aeruginosa. Yates SP, Taylor PL, Jørgensen R, Ferraris D, Zhang J, Andersen GR, Merrill AR. Biochem J; 2005 Feb 01; 385(Pt 3):667-75. PubMed ID: 15458385 [Abstract] [Full Text] [Related]
7. Structural complementation of the catalytic domain of pseudomonas exotoxin A. Boland EL, Van Dyken CM, Duckett RM, McCluskey AJ, Poon GM. J Mol Biol; 2014 Feb 06; 426(3):645-55. PubMed ID: 24211469 [Abstract] [Full Text] [Related]
8. Investigation into the catalytic role for the tryptophan residues within domain III of Pseudomonas aeruginosa exotoxin A. Beattie BK, Prentice GA, Merrill AR. Biochemistry; 1996 Dec 03; 35(48):15134-42. PubMed ID: 8952460 [Abstract] [Full Text] [Related]
9. Stealth and mimicry by deadly bacterial toxins. Yates SP, Jørgensen R, Andersen GR, Merrill AR. Trends Biochem Sci; 2006 Feb 03; 31(2):123-33. PubMed ID: 16406634 [Abstract] [Full Text] [Related]
10. A re-evaluation of the role of histidine-426 within Pseudomonas aeruginosa exotoxin A. Roberts TM, Merrill AR. Biochem J; 2002 Nov 01; 367(Pt 3):601-8. PubMed ID: 12160465 [Abstract] [Full Text] [Related]
11. Human single-chain antibodies that neutralize Pseudomonas aeruginosa-exotoxin A-mediated cellular apoptosis. Santajit S, Seesuay W, Mahasongkram K, Sookrung N, Ampawong S, Reamtong O, Diraphat P, Chaicumpa W, Indrawattana N. Sci Rep; 2019 Oct 17; 9(1):14928. PubMed ID: 31624289 [Abstract] [Full Text] [Related]
13. An enzyme-linked immunosorbent assay for the association of the catalytic domain of diphthamide-specific ribosyltransferases to eukaryotic elongation factor-2. Prentice GA, Merrill AR. Anal Biochem; 1999 Aug 01; 272(2):216-23. PubMed ID: 10415091 [Abstract] [Full Text] [Related]
14. Diphtheria toxin and Pseudomonas aeruginosa exotoxin A: active-site structure and enzymic mechanism. Wilson BA, Collier RJ. Curr Top Microbiol Immunol; 1992 Aug 01; 175():27-41. PubMed ID: 1628498 [No Abstract] [Full Text] [Related]
15. Refined crystallographic structure of Pseudomonas aeruginosa exotoxin A and its implications for the molecular mechanism of toxicity. Wedekind JE, Trame CB, Dorywalska M, Koehl P, Raschke TM, McKee M, FitzGerald D, Collier RJ, McKay DB. J Mol Biol; 2001 Dec 07; 314(4):823-37. PubMed ID: 11734000 [Abstract] [Full Text] [Related]
17. Pseudomonas exotoxin A mutants. Replacement of surface exposed residues in domain II with cysteine residues that can be modified with polyethylene glycol in a site-specific manner. Kuan CT, Wang QC, Pastan I. J Biol Chem; 1994 Mar 11; 269(10):7610-6. PubMed ID: 8125985 [Abstract] [Full Text] [Related]
18. The crystal structure of Pseudomonas aeruginosa exotoxin domain III with nicotinamide and AMP: conformational differences with the intact exotoxin. Li M, Dyda F, Benhar I, Pastan I, Davies DR. Proc Natl Acad Sci U S A; 1995 Sep 26; 92(20):9308-12. PubMed ID: 7568123 [Abstract] [Full Text] [Related]
19. Characterization of competitive inhibitors for the transferase activity of Pseudomonas aeruginosa exotoxin A. Armstrong S, Li JH, Zhang J, Merrill AR. J Enzyme Inhib Med Chem; 2002 Aug 26; 17(4):235-46. PubMed ID: 12530476 [Abstract] [Full Text] [Related]
20. The role of the diphthamide-containing loop within eukaryotic elongation factor 2 in ADP-ribosylation by Pseudomonas aeruginosa exotoxin A. Zhang Y, Liu S, Lajoie G, Merrill AR. Biochem J; 2008 Jul 01; 413(1):163-74. PubMed ID: 18373493 [Abstract] [Full Text] [Related] Page: [Next] [New Search]